Clinical trialNCT07218510RecruitingPhase 2Interventional

Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial

SponsorCity of Hope Medical CenterEnrollment33Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Alexey V Danilov
City of Hope Medical Center
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

City of Hope Medical Center
Duarte, California, United States
Alexey V. Danilov
Recruiting
City of Hope at Irvine Lennar
Irvine, California, United States
Alexey V. Danilov
Recruiting
City of Hope at Long Beach Elm
Long Beach, California, United States
Alexey V. Danilov
Recruiting
University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
Georgios Pongas
Not, yet, recruiting
City of Hope Atlanta Cancer Center
Newnan, Georgia, United States
Alexey V. Danilov
Recruiting
Laura and Isaac Perlmutter Cancer Center at Nyu Langone
New York, New York, United States
John P. Leonard
Not, yet, recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Guru Subramanian Guru Murthy
Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 7 Jan 2026
Primary completion: 8 Jun 2029
Completion: 8 Jun 2029
Last update posted: 13 Mar 2026
Registered enrollment: 33
Registry id: NCT07218510

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.